Nordicus Partners Corporation is a financial consulting company specializing in providing Nordic companies with the best possible conditions to establish themselves on the U.S. market, taking advantage of management’s combined 90+ years of experience in the corporate sector, serving in different capacities both domestically and globally. The company’s core competencies lie in assisting Danish as well as other Nordic and international companies in different areas of corporate finance activities, such as: business valuations, growth strategies, attracting capital for businesses & company acquisitions and sales.
Company profile
Ticker
NORD
Exchange
Website
CEO
Michael F. Adams
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
AdvanSource Biomaterials Corp, CARDIOTECH INTERNATIONAL INC, EKIMAS Corp
SEC CIK
Corporate docs
IRS number
43186647
NORD stock data
Latest filings (excl ownership)
S-1
IPO registration
19 Sep 23
10-Q
2023 Q1
Quarterly report
18 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
10-K/A
2023 FY
Annual report (amended)
19 Jul 23
10-K
2023 FY
Annual report
14 Jul 23
NT 10-K
Notice of late annual filing
29 Jun 23
8-K
Entry into a Material Definitive Agreement
20 Jun 23
8-K
Departure of Directors or Certain Officers
13 Jun 23
8-K
Changes in Registrant's Certifying Accountant
23 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
22 May 23
Latest ownership filings
SC 13D/A
GK Partners ApS
18 Sep 23
4
Change in insider ownership
13 Sep 23
SC 13D/A
Rouf Henrik
31 Aug 23
4
Henrik Rouf
31 Aug 23
4
Henrik Rouf
8 Aug 23
4
Henrik Oerbekker
23 Jun 23
3
Henrik Oerbekker
8 Sep 22
SC 13D
Oerbekker Henrik
8 Sep 22
3
Partners ApS Gk
21 Jul 22
SC 13D
Gk Partners ApS
21 Jul 22
Financial summary
| Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 32.04 k | 32.04 k | 32.04 k | 32.04 k | 32.04 k | 32.04 k |
| Cash burn (monthly) | (no burn) | 12.83 k | 17.20 k | 290.90 k | 16.00 | 25.70 k |
| Cash used (since last report) | n/a | 36.15 k | 48.45 k | 819.55 k | 45.08 | 72.41 k |
| Cash remaining | n/a | -4.11 k | -16.41 k | -787.51 k | 31.99 k | -40.37 k |
| Runway (months of cash) | n/a | -0.3 | -1.0 | -2.7 | 1999.7 | -1.6 |
Institutional ownership, Q2 2023
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Jan 23 | Oerbekker Henrik | Common Stock | Sell | Dispose S | No | No | 0.5 | 500,000 | 250.00 k | 278,618 |
| 23 Aug 22 | Rouf Henrik | Common Stock | Gift | Dispose G | No | No | 0 | 100,000 | 0.00 | 835,018 |
| 17 May 22 | Rouf Henrik | Common Stock | Buy | Dispose P | Yes | No | 0.0001 | 778,618 | 77.86 | 778,618 |
| 17 May 22 | Rouf Henrik | Common Stock | Buy | Dispose P | Yes | No | 0.04 | 3,557,239 | 142.29 k | 1,557,236 |